Therefore, previous studies reported the following findings: the abnormal expression of MRPS23 might serve as a poor prognostic factor of the tumor size in hepatocellular carcinomas [53], breast cancers [55], and cervical cancer [54]. Here, MRPS23 is linked to breast carcinoma.